Dare Bioscience | Investor Presentation Deck

Slide schematic 4/4

list 1/1 paragraph 2/2 title 1/1

Components 4

bullet paragraph paragraph headline

Tools 1

Planned next steps include activities related to psychometric analyses of the Phase 2b study dataset to further refine the measures and resulting endpoints from the completed study for use in a Phase

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 0

∅

No frameworks

No framework match is anchored to this slide.

Find anything

Focuses on regulatory strategy and clinical trial design parameters for Phase 3.